Detalhe da pesquisa
1.
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview.
Curr Issues Mol Biol
; 46(4): 3039-3049, 2024 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666920
2.
Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease.
Q J Nucl Med Mol Imaging
; 68(2): 95-100, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860273
3.
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy.
Q J Nucl Med Mol Imaging
; 68(2): 101-115, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860274
4.
Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging.
Eur Radiol
; 33(10): 7199-7208, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37079030
5.
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer.
Q J Nucl Med Mol Imaging
; 67(2): 167-173, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34477346
6.
Radionuclide Delivery Strategies in Tumor Treatment: A Systematic Review.
Curr Issues Mol Biol
; 44(8): 3267-3282, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35892711
7.
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review.
Curr Issues Mol Biol
; 44(11): 5516-5530, 2022 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36354685
8.
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome.
Oncologist
; 27(2): e199-e202, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641202
9.
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review.
Int J Mol Sci
; 23(21)2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362190
10.
PET/MRI in prostate cancer: a systematic review and meta-analysis.
Eur J Nucl Med Mol Imaging
; 48(3): 859-873, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32901351
11.
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases.
Eur J Nucl Med Mol Imaging
; 48(5): 1522-1537, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619599
12.
Challenges in theragnostics.
Q J Nucl Med Mol Imaging
; 65(4): 371-375, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881849
13.
Copper, PET/CT and prostate cancer: a systematic review of the literature.
Q J Nucl Med Mol Imaging
; 64(4): 382-392, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32900177
14.
Molecular Imaging of Pulmonary Inflammation and Infection.
Int J Mol Sci
; 21(3)2020 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32019142
15.
Something still missing in molecular imaging: CXCR2 axis in prostate cancer.
Eur J Nucl Med Mol Imaging
; 51(3): 615-617, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935994
16.
Renal function assessment after embolization of vascular complications following partial nephrectomy.
BJU Int
; 133(1): 46-48, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37607303
17.
Structured reporting in prostate cancer: the revolution of quality in nuclear medicine scan interpretation.
Eur Radiol
; 34(2): 1155-1156, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123691
18.
The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment.
Q J Nucl Med Mol Imaging
; 68(2): 93-94, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860272
19.
The future of choline PET in the era of prostate specific membrane antigen.
Q J Nucl Med Mol Imaging
; 63(1): 19-28, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29383928
20.
The effects of androgen deprivation therapy on the 18F-Chcoline uptake in prostate cancer patients undergoing neoadjuvant treatment.
Q J Nucl Med Mol Imaging
; 63(3): 278-283, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27387380